Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 11/20 | 0.49 |
| ▸ | VCP | P55072 | 4/20 | 0.47 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.47 |
| ▸ | FLT3 | P36888 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.43 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.43 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1642784 | 0.92 | FGFR2 (0.54) | ATRVCPFGFR2FLT3CDK1 | |
| Trifluoroacetic Acid SCHEMBL27909280 | 0.91 | FGFR2 (0.58) | ATRVCPFGFR2FLT3CDK1 | |
| SCHEMBL1640841 | 0.81 | FGFR2 (0.69) | ATRVCPFGFR2FLT3CDK1 | |
| SCHEMBL1640855 | 0.79 | FGFR2 (0.50) | ATRVCPFGFR2FLT3CDK1 | |
| SCHEMBL1642585 | 0.76 | FGFR2 (0.78) | ATRFGFR2FLT3CYP3A4KDR | |
| SCHEMBL1642894 | 0.72 | EGFR (0.56) | VCPFGFR2FLT3CDK1KDR | |
| SCHEMBL5482972 | 0.70 | KDR (0.43) | VCPCDK1KDR | |
| SCHEMBL1642621 | 0.67 | FGFR2 (0.81) | ATRFGFR2FLT3KDR | |
| SCHEMBL28028563 | 0.67 | NR4A1 (0.59) | — | |
| SCHEMBL1641379 | 0.66 | FGFR2 (0.67) | ATRFGFR2FLT3KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101970418-B | Pyrazine derivative and its uses as protein kinase inhibitor | AKINION PHARMACEUTICALS AB | 2013-07-03 | — | — | CN | claimed |